# ALI Pharmaceutical Manufacturing LLC - Inspection Records

Source: https://www.keypedia.com/companies/ali-pharmaceutical-manufacturing-llc/d3d0fcce-e7cb-4f71-8042-2726fd64e8a8

> Inspection records and compliance data for ALI Pharmaceutical Manufacturing LLC in Omaha, Nebraska. Access full analysis and detailed observations.

---

## Details

- Name: ALI Pharmaceutical Manufacturing LLC
- FEI Number: 1920841
- City: Omaha
- State: Nebraska
- Country Name: United States
- Address Line 1: 4410 S 102nd St
- Zip Code: 68127

## Related Documents

- [483 - ALI Pharmaceutical Manufacturing LLC - 2024-05-03](https://www.keypedia.com/records/483/ali-pharmaceutical-manufacturing-llc/102d7b3d-d9ab-490f-9da6-b177fa57520e) — source: FDA, date: May 3, 2024
- [FDA Inspection 1237967 - ALI Pharmaceutical Manufacturing LLC - 2024-05-03](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/180aed48-8cdf-4012-b888-5ed251953633) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2024
- [483 - ALI Pharmaceutical Manufacturing LLC - 2022-10-03](https://www.keypedia.com/records/483/ali-pharmaceutical-manufacturing-llc/eb3ce62b-f9e0-4656-8cf3-1dd1591cf58a) — source: FDA, date: October 3, 2022
- [483 - ALI Pharmaceutical Manufacturing LLC - 2022-10-03](https://www.keypedia.com/records/483/ali-pharmaceutical-manufacturing-llc/dd111a0f-1896-4c7d-aea0-dbd4f3efc866) — source: FDA, date: October 3, 2022
- [FDA Inspection 1187283 - ALI Pharmaceutical Manufacturing LLC - 2022-10-03](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/6d5e0a59-a25e-4f9a-ad78-56095ae55021) — classification: Official Action Indicated (OAI), source: FDA, date: October 3, 2022
- [483 - ALI Pharmaceutical Manufacturing LLC - 2017-12-01](https://www.keypedia.com/records/483/ali-pharmaceutical-manufacturing-llc/2cd46e70-9b2a-475f-92d5-516cc6921f0a) — source: FDA, date: December 1, 2017
- [FDA Inspection 1037205 - ALI Pharmaceutical Manufacturing LLC - 2017-12-01](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/07c6571c-adfc-41ab-b7a6-ccb13326641e) — classification: No Action Indicated (NAI), source: FDA, date: December 1, 2017
- [FDA Inspection 1037205 - ALI Pharmaceutical Manufacturing LLC - 2017-12-01](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/5a98fab9-8e3b-4daf-b916-cde3595b0fa3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 1, 2017
- [FDA Inspection 1037205 - ALI Pharmaceutical Manufacturing LLC - 2017-12-01](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/2c9312f8-a958-4135-b224-253a4a302cb3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 1, 2017
- [FDA Inspection 951530 - ALI Pharmaceutical Manufacturing LLC - 2015-09-04](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/10ef1f43-8154-4d13-a232-c770fbc4c62a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 4, 2015
- [FDA Inspection 951530 - ALI Pharmaceutical Manufacturing LLC - 2015-09-04](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/7551ce36-0b61-48bb-91b0-d03f0ad3fde2) — classification: No Action Indicated (NAI), source: FDA, date: September 4, 2015
- [FDA Inspection 951530 - ALI Pharmaceutical Manufacturing LLC - 2015-09-04](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/1646f4bb-cc60-40b7-9438-7ace203c7d47) — classification: No Action Indicated (NAI), source: FDA, date: September 4, 2015
- [FDA Inspection 806926 - ALI Pharmaceutical Manufacturing LLC - 2012-11-19](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/2a4fbc44-0a67-42dd-b648-1dfcef37898c) — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2012
- [FDA Inspection 806926 - ALI Pharmaceutical Manufacturing LLC - 2012-11-19](https://www.keypedia.com/records/fda_inspections/ali-pharmaceutical-manufacturing-llc/4b7ad924-5cf8-4fb8-a54b-ac2adc2517c2) — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2012

## Related Companies

- [J.M Huber Micropowders, Inc](https://www.keypedia.com/companies/jm-huber-micropowders-inc/29e05493-3c2b-4d4b-ac8d-da0ba1cefba8)
- [VUAB Pharma a.s.](https://www.keypedia.com/companies/vuab-pharma-as/6caae203-57d0-4a6f-b2b8-340c40ec5135)
- [Shouguang Fukang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shouguang-fukang-pharmaceutical-co-ltd/c6836369-cde1-4980-97c8-314af897d7e1)
- [Cambridge Isotope Laboratories, Inc.](https://www.keypedia.com/companies/cambridge-isotope-laboratories-inc/bb7d8566-a216-469b-88ac-a3fa0060927e)
- [Alivira Animal Health Limited](https://www.keypedia.com/companies/alivira-animal-health-limited/8bb7e2de-7191-4fee-8834-335e5a8cd50e)
- [PMC Biogenix, Inc.](https://www.keypedia.com/companies/pmc-biogenix-inc/01f14e73-d7ae-4ee7-853f-0d99b1ea8165)
- [IOI OLEO GMBH](https://www.keypedia.com/companies/ioi-oleo-gmbh/76de4547-287b-433f-a620-69b70610edd4)
- [FluoroMed Products, L.P.](https://www.keypedia.com/companies/fluoromed-products-lp/90335b00-e469-483f-9254-5f43d663c574)
- [Amicogen (China) Biopharm Co., Ltd.](https://www.keypedia.com/companies/amicogen-china-biopharm-co-ltd/f3e49436-c792-47f7-ba7a-17d61c7306af)
- [Herbamed AG](https://www.keypedia.com/companies/herbamed-ag/d4987d1a-9073-4e45-ba78-0c4fe49241ef)

## Related Officers

- [Program Expert ](https://www.keypedia.com/people/michele-l-obert/7ac8155e-cc5a-4e89-a885-c68ce69adb4e)
- [investigator](https://www.keypedia.com/people/diana-k-krepel/6dfec9cd-a933-4d1e-947c-cebb5891796c)
- [Director](https://www.keypedia.com/people/joann-m/0a459cd4-7849-4687-8811-4868144e3be3)
- [Brent M. Dehaan](https://www.keypedia.com/people/brent-m-dehaan/7a6af4a2-2566-48af-b59d-dd59008ff997)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)